- Home
- ADSE vs SLP Comparison
ADSE vs SLP Comparison
Compare ADSE & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSE
- SLP
- Stock Information
- Founded
- ADSE 1980
- SLP 1996
- Country
- ADSE Ireland
- SLP United States
- Employees
- ADSE N/A
- SLP N/A
- Industry
- ADSE Industrial Specialties
- SLP EDP Services
- Sector
- ADSE Consumer Discretionary
- SLP Technology
- Exchange
- ADSE Nasdaq
- SLP Nasdaq
- Market Cap
- ADSE 777.7M
- SLP 708.1M
- IPO Year
- ADSE N/A
- SLP 1997
- Fundamental
- Price
- ADSE $13.29
- SLP $30.02
- Analyst Decision
- ADSE Hold
- SLP Buy
- Analyst Count
- ADSE 1
- SLP 8
- Target Price
- ADSE $14.00
- SLP $47.83
- AVG Volume (30 Days)
- ADSE 65.6K
- SLP 451.7K
- Earning Date
- ADSE 05-16-2025
- SLP 07-01-2025
- Dividend Yield
- ADSE N/A
- SLP 0.20%
- EPS Growth
- ADSE N/A
- SLP N/A
- EPS
- ADSE N/A
- SLP 0.36
- Revenue
- ADSE $158,974,606.00
- SLP $78,564,000.00
- Revenue This Year
- ADSE $107.27
- SLP $30.38
- Revenue Next Year
- ADSE $57.96
- SLP $11.97
- P/E Ratio
- ADSE N/A
- SLP $83.36
- Revenue Growth
- ADSE 168.42
- SLP 21.49
- 52 Week Low
- ADSE $10.17
- SLP $23.01
- 52 Week High
- ADSE $16.35
- SLP $51.22
- Technical
- Relative Strength Index (RSI)
- ADSE 49.63
- SLP 45.26
- Support Level
- ADSE $13.02
- SLP $27.85
- Resistance Level
- ADSE $13.53
- SLP $36.45
- Average True Range (ATR)
- ADSE 0.65
- SLP 1.59
- MACD
- ADSE 0.06
- SLP -0.75
- Stochastic Oscillator
- ADSE 60.19
- SLP 25.23
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.